ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

HHS Appoints 13 To Genetics Committee

January 17, 2003

NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System

August 26, 1977

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

April 22, 2005

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

DCCP Payback System Saving $1 Million Year

December 3, 1982